A detailed history of Shell Asset Management CO transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Shell Asset Management CO holds 6,246 shares of IOVA stock, worth $46,782. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,246
Previous 6,284 0.6%
Holding current value
$46,782
Previous $50,000 18.0%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$7.28 - $11.9 $276 - $452
-38 Reduced 0.6%
6,246 $59,000
Q1 2024

Jul 31, 2024

SELL
$7.59 - $17.47 $2,884 - $6,638
-380 Reduced 5.7%
6,284 $50,000
Q1 2024

May 14, 2024

SELL
$7.59 - $17.47 $2,254 - $5,188
-297 Reduced 4.27%
6,664 $99,000
Q4 2023

Feb 14, 2024

SELL
$3.3 - $8.89 $6,900 - $18,588
-2,091 Reduced 23.1%
6,961 $57,000
Q3 2023

Nov 08, 2023

SELL
$4.44 - $8.79 $630 - $1,248
-142 Reduced 1.54%
9,052 $41,000
Q2 2023

Jul 28, 2023

SELL
$5.36 - $9.06 $284 - $480
-53 Reduced 0.57%
9,194 $65,000
Q1 2023

May 15, 2023

SELL
$5.53 - $8.22 $182 - $271
-33 Reduced 0.36%
9,247 $56,000
Q4 2022

Feb 07, 2023

SELL
$5.62 - $10.0 $10,588 - $18,840
-1,884 Reduced 16.88%
9,280 $59,000
Q3 2022

Nov 14, 2022

SELL
$9.53 - $13.11 $27,865 - $38,333
-2,924 Reduced 20.76%
11,164 $107,000
Q2 2022

Aug 09, 2022

BUY
$6.38 - $18.33 $146 - $421
23 Added 0.16%
14,088 $156,000
Q1 2022

May 04, 2022

SELL
$12.38 - $19.1 $25,775 - $39,766
-2,082 Reduced 12.89%
14,065 $234,000
Q4 2021

Feb 09, 2022

BUY
$16.55 - $27.63 $1,290 - $2,155
78 Added 0.49%
16,147 $308,000
Q3 2021

Nov 04, 2021

SELL
$20.35 - $26.63 $14,041 - $18,374
-690 Reduced 4.12%
16,069 $396,000
Q2 2021

Aug 12, 2021

BUY
$16.33 - $33.07 $273,674 - $554,220
16,759 New
16,759 $436,000
Q1 2021

May 10, 2021

SELL
$28.67 - $52.59 $360,496 - $661,266
-12,574 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$28.04 - $50.26 $176,399 - $316,185
6,291 Added 100.13%
12,574 $583,000
Q3 2020

Nov 13, 2020

BUY
$27.75 - $36.3 $174,353 - $228,072
6,283 New
6,283 $207,000

Others Institutions Holding IOVA

About IOVANCE BIOTHERAPEUTICS, INC.


  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $1.18B
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Shell Asset Management CO Portfolio

Follow Shell Asset Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.